Home » Topics » BioWorld Science

BioWorld Science
RSS

Clovis seeks to expand use of Rubraca in E.U. in recurrent ovarian cancer

June 5, 2018

FDA clears Nant to begin clinical trials with neoepitope yeast vaccine YE-NEO-011

June 5, 2018

FDA approves pegfilgrastim biosimilar Fulphila

June 5, 2018

Versartis and Aravive Biologics enter merger agreement

June 5, 2018

Interim results presented from phase I trial of PIN-2 in patients with solid tumors

June 5, 2018

FDA accepts NDA filing for bremelanotide for hypoactive sexual desire disorder

June 5, 2018

Evoke submits NDA to the FDA for Gimoti

June 5, 2018

Zenith advances trial of ZEN-3694 in metastatic CRPC into phase II

June 5, 2018

PFK/FBPase 1 inhibitors identified at Merck KGaA

June 5, 2018

First-in-human results from Millennium's TAK-931 in advanced solid tumors

June 5, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...